Articles by Daniel Carlat, MD

Clinical Guidance

The Psychiatric Review of Symptoms

August 1, 2026

Dr. Carlat has no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

The psychiatric review of symptoms (PROS) is an important though often neglected part of the initial psychiatric evaluation

Clinical Guidance

Telepsychiatry in Hospital Psychiatry

August 1, 2026

Victoria Hendrick, MD and Daniel Carlat, MD

Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Telepsychiatry has become a standard part of emergency and inpatient hospital care, driven by workforce shortages, after-hours coverage needs, and lasting changes from the COVID-19 pandemic.

Clinical Guidance

IV Ketamine Treatment on the Inpatient Unit

August 1, 2026

Victoria Hendrick, MD and Daniel Carlat, MD

Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

IV ketamine's rapid antidepressant and anti-suicidal effects make it well suited to the inpatient timeline, where the 6–8-week lag of standard antidepressants is often untenable.

Clinical Guidance

Advance Directives: Guiding Patients Toward Dignity and Autonomy

August 1, 2026

Victoria Hendrick, MD and Daniel Carlat, MD

Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Liver function tests (LFTs) are critical in psychiatry because the liver metabolizes most psychotropic medications, and because heavy alcohol or substance use may impair hepatic function.

Rethinking 12-Step Referrals

June 13, 2026

Daniel Carlat, MD

How to make a 12-step referral patients will actually try.

Free Sample Resource - Most Common Clinically Significant Drug Interactions in Psychiatry

June 6, 2026

Victoria Hendrick, MD and Daniel Carlat, MD

Drug-drug interactions are critical to monitor in older adults due to the high prevalence of polypharmacy in this population.

The Benefits of Exercise in Older Adults

June 5, 2026

Daniel Carlat, MD

We tell patients to exercise. We're usually vague about the dose. A 2025 UK Biobank study (Yu K et al, Am J Geriatr Psychiatry 2025;33(5):512–523 https://lnkd.in/eVAh4Dtq) put real numbers on it — using accelerometers, not self-report. The design: 71,556 adults. Mean age 62. No depression or anxiety at baseline. Followed a median of 8 years.

When Social Withdrawal Becomes Invisible Pathology

May 8, 2026

Daniel Carlat, MD

Have you ever heard of hikikomori? Literally: "pulling inward."

First described by Japanese psychiatrist Tamaki Saito in 1998 — and for decades assumed to be a uniquely Japanese problem.

It isn't.

A 2025 meta-analysis of 19 studies and 58,000+ participants found cases across Europe, North America, and beyond. US estimates put prevalence around 2–3%. Roughly 1 in 40 Americans.

Fact Sheet

How to Use AI Scribes in Psychiatry

April 24, 2026

Victoria Hendrick, MD and Daniel Carlat, MD

Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

AI scribes automatically generate structured clinical notes from recorded patient interviews, saving psychiatrists significant documentation time and reducing after-hours charting.

Fact Sheet

Genetic Conditions With Psychiatric Manifestations

April 24, 2026

Victoria Hendrick, MD and Daniel Carlat, MD

Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Many genetic neurodevelopmental disorders are diagnosed in childhood—but some patients reach adulthood undiagnosed, particularly if earlier evaluations were limited or never pursued.